These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20406202)

  • 1. Systemic hyperthermia masks the neuroprotective effects of MK-801, but not rosiglitazone in brain ischaemia.
    Nategh M; Shaveisi K; Shabanzadeh AP; Sadr SSh; Parviz M; Ghabaei M
    Basic Clin Pharmacol Toxicol; 2010 Sep; 107(3):724-9. PubMed ID: 20406202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.
    Allahtavakoli M; Shabanzadeh A; Roohbakhsh A; Pourshanazari A
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):309-14. PubMed ID: 17910613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
    Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
    Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1-induced cerebral ischemia: effects of ketanserin and MK-801 on limb placing in rats.
    Moyanova S; Kortenska L; Mitreva R
    Int J Neurosci; 2007 Sep; 117(9):1361-81. PubMed ID: 17654097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
    Katsuta K; Nakanishi H; Shirakawa K; Yoshida K; Takagi K; Tamura A
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal assessment of neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia.
    Moyanova SG; Kortenska LV; Mitreva RG; Pashova VD; Ngomba RT; Nicoletti F
    Brain Res; 2007 Jun; 1153():58-67. PubMed ID: 17466282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y; Li Q; Shuaib A
    Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.
    Allahtavakoli M; Shabanzadeh AP; Sadr SS; Parviz M; Djahanguiri B
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1052-8. PubMed ID: 17042914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effect of dl-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia].
    Liu XG; Feng YP
    Yao Xue Xue Bao; 1995 Dec; 30(12):896-903. PubMed ID: 8712015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.
    Tanaka Y; Marumo T; Omura T; Yoshida S
    Brain Res; 2007 Jun; 1154():194-9. PubMed ID: 17475227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pre-ischaemic neuroprotective effects of N1-dansyl-spermine in a transient focal cerebral ischaemia model in mice.
    Li J; Henman MC; Tatlisumak T; Shaw GG; Doyle KM
    Brain Res; 2005 Sep; 1055(1-2):180-5. PubMed ID: 16095573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia.
    Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
    J Cereb Blood Flow Metab; 1988 Oct; 8(5):757-62. PubMed ID: 2901425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.
    Zhao Y; Patzer A; Gohlke P; Herdegen T; Culman J
    Eur J Neurosci; 2005 Jul; 22(1):278-82. PubMed ID: 16029218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia-reperfusion injury in rats.
    Dhote V; Balaraman R
    Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):630-7. PubMed ID: 18318745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of MK-801 on infarct development over a period of 24 h as assessed by diffusion-weighted magnetic resonance imaging.
    Gill R; Sibson NR; Maskell L; Carpenter TA; Hall LD; Pickard JD
    NMR Biomed; 1996 Sep; 9(6):241-8. PubMed ID: 9073302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion: adverse effects of hypothalamic damage and strategies for its avoidance.
    Gerriets T; Stolz E; Walberer M; Kaps M; Bachmann G; Fisher M
    Stroke; 2003 Sep; 34(9):2234-9. PubMed ID: 12920258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
    Patzer A; Zhao Y; Stöck I; Gohlke P; Herdegen T; Culman J
    Eur J Neurosci; 2008 Nov; 28(9):1786-94. PubMed ID: 18973594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
    Lestage P; Lockhart B; Roger A
    Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.